Brief: Frequency Therapeutics Shares Results from FX-322-113 Severe Sensorineural Hearing Loss Study Showing Speech Perception Improvements in Noise

Korro Bio

09/12/2021 14:15

Dec 9 (Reuters) - Frequency Therapeutics Inc  FREQ.O :
    * FREQUENCY THERAPEUTICS SHARES RESULTS FROM FX-322-113
SEVERE
SENSORINEURAL HEARING LOSS STUDY SHOWING SPEECH PERCEPTION
IMPROVEMENTS IN NOISE
    * FREQUENCY THERAPEUTICS INC- IN STUDY, FX-322 WAS
ASSOCIATED WITH
A HEARING SIGNAL AS SHOWN BY IMPROVEMENTS BY FOUR SUBJECTS IN
SENTENCE-IN-NOISE TEST
    * FREQUENCY THERAPEUTICS INC- IN FX-322-113 STUDY, SUBJECTS
DID
NOT SHOW SUBSTANTIAL CHANGES IN SPEECH PERCEPTION MEASURES IN
QUIET
    * FREQUENCY THERAPEUTICS INC- SAFETY PROFILE IN FX-322-113
STUDY
WAS FAVORABLE AND THERE WERE NO TREATMENT-RELATED SERIOUS
ADVERSE EVENTS REPORTED

Source text for Eikon:  ID:nBw5Dj0FHa 
Further company coverage:  FREQ.O 

 ((Reuters.Briefs@thomsonreuters.com;;))